Skip to main content
Explore URMC

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC PB1046 in Subjects With Symptomatic PAH

Research Question:
Does the drug PB1046 help patients who have pulmonary arterial hypertension?

Basic Study Information

Pulmonary arterial hypertension (PAH) is one form of a broader condition known as pulmonary hypertension, which means high blood pressure in the lungs. This is a multi-center, randomized, double-blind, controlled, Phase 2 study to assess the safety, tolerability, and efficacy of PB1046 in patients with pulmonary arterial hypertension.

Location: University of Rochester Medical Center

Study Contact Information

Study Coordinator: Andrew Mintz, RN
Phone: (585) 486-0869

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search